Turkish - Swiss Pharmaceutical & Bioceutical Technology Transfer Project is a mutually driven effort with regards to effective transferring of 209 pharmaceutical and bioceutical patented formulations invented by Erdal Can Alkoclar and Metehan Yesil to Switzerland.

Above mentioned patented formulations include:

BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS

WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF SWITZERLAND TO PROVIDE AN EFFECTIVE CONTRIBUTION TO COLLECTIVE HEALTH.

BEST REGARDS

Erdal Can ALKOCLAR & Metehan YESIL